Newslaundry1h
A former GBS patient on the facts and sensationalism surrounding the outbreak
GBS has occasionally made the news before. During the pandemic, it was listed as a side-effect for a Covid vaccine. In 2023, ...
Survivor shares the first symptoms of deadly Guillian Barré Syndrome that everyone should know
Guillain-Barré Syndrome is rare but can happen to anyone. Recognizing the first symptoms—tingling, weakness, difficulty ...
Pune GBS Outbreak: 21-Year-Old Student From Baramati Dies Due To GBS, Death Tally Reaches At 10
In the 10th case of death due to Guillain-Barré Syndrome (GBS) in Pune, a 21-year-old girl, Kiran Rajendra Deshmukh, has died ...
Reduce risk of developing Guillain Barre Syndrome (GBS) with these 9 doctor-approved steps
Despite taking all the precautions, if you develop symptoms of GBS, do not panic, Dr Sudhir Kumar advised. 'Consult a ...
211 Guillain-Barré Syndrome cases reported in Maharashtra so far
The suspected and confirmed Guillain-Barré Syndrome cases in Maharashtra increased to 211 on Tuesday after a new case was ...
GBS Outbreak In Maharashtra: Guillain-Barre Syndrome Cases Tally Rises To 211; 139 Discharged So Far
Mumbai: The number of suspected and confirmed cases of Guillain-Barré Syndrome (GBS) in Maharashtra has risen to 211 as of ...
GBS is not pandemic, government providing free treatment, says Additional DME
Following the outbreak of Guillain-Barré Syndrome (GBS) in Pune and four deaths and 45 cases reported in the State, public awareness of the disease has grown si ...
Guillain-Barré Syndrome case count at 211: State health secretary calls for stricter hygiene, close monitoring of diarrhoea cases
The state health secretary added that GBS is a rare neurological disorder and the autoimmune reactions can occur four to six ...
GBS outbreak in Pune: 183 cases diagnosed, 9 deaths reported
Pune is witnessing a surge in Guillain-Barré Syndrome (GBS) cases, with 183 diagnosed and 9 deaths reported. Health ...
Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Moderna has limited upside: Barclays
Barclays downgraded Moderna (NASDAQ:MRNA) to Equal Weight from Overweight in a note Tuesday, citing policy risks, a lack of major clinical catalysts, and macroeconomic uncertainties that limit the ...